Australia - English - Department of Health (Therapeutic Goods Administration)

ecomed pty ltd - 45084 - ophthalmologic/otologic diagnostic set - a set of devices used by a physician to perform an ophthalmic and/or otoscopic clinical examination on a patient. the set is typically enclosed in a case and including an otoscope & ophthalmoscope.

Australia - English - Department of Health (Therapeutic Goods Administration)

boian surgical pty ltd - 45084 - ophthalmologic/otologic diagnostic set - a collection of battery-powered devices used to perform an ophthalmic and/or otoscopic clinical examination on a patient that are enclosed in a dedicated case. although this is a reusable device, examination sets may also contain some single-use devices.

Australia - English - Department of Health (Therapeutic Goods Administration)

heine aust pty ltd - 45084 - ophthalmologic/otologic diagnostic set - combined set designed to shine light onto the body

Australia - English - Department of Health (Therapeutic Goods Administration)

medeleq australia pty ltd - 45084 - ophthalmologic/otologic diagnostic set - eent and physical examination instruments for examination of the inner ear, eye and skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

lead business group medical pty ltd - 45084 - ophthalmologic/otologic diagnostic set - eent and physical examination instruments for examination of the inner ear, eye and skin.

Australia - English - Department of Health (Therapeutic Goods Administration)

swirl technologies pty ltd t/a parker healthcare - 45084 - ophthalmologic/otologic diagnostic set - a system of devices intended for external ear, general ophthalmic and general non-invasive examination.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited  - voretigene neparvovec - leber congenital amaurosis; retinitis pigmentosa - other ophthalmologicals - luxturna is indicated for the treatment of adult and paediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic rpe65 mutations and who have sufficient viable retinal cells.

Australia - English - Department of Health (Therapeutic Goods Administration)

welch allyn australia pty limited -

Australia - English - Department of Health (Therapeutic Goods Administration)

welch allyn australia pty limited -

Australia - English - Department of Health (Therapeutic Goods Administration)

sp services (aus) llp -